Search Results 101-110 of 15371 for TNF
Cholestatic liver injury. The overall objective of this proposal is to examine the hypothesis that ductular reactive cells induce macrophage TNF-related ...
... TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of refractory or intolerance to CS and/or IS may have been previously exposed to anti ...
... tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), total tau protein (t-Tau), insulin-like growth factor 1 (IGF-1), brain-derived neurotrophic ...
... tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses to ...
Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J ...
Tumor necrosis factor-alpha (TNF-alpha) inhibitors. These medicines are commonly used to treat inflammation from rheumatoid arthritis. They also can be ...
... Tumor Necrosis Factor (TNF) therapy. A Study of Efficacy and Safety of ... tumor necrosis factor (TNF-IR). Participants who enroll on the basis of ...
CAPS is a rare, inherited disease of the immune system. Canakinumab injection is also used to treat tumor necrosis factor receptor associated periodic syndrome ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.